Share Price and Basic Stock Data
Last Updated: February 6, 2026, 4:22 pm
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Envair Electrodyne Ltd operates in the electric equipment sector, focusing on gensets and turbines. The company’s stock price is currently ₹66.5, and its market capitalization stands at ₹30.9 Cr. Revenue generation has been inconsistent; for the quarter ending September 2023, sales recorded ₹0.31 Cr, following a preceding quarter of ₹0.00 Cr. The company has experienced fluctuating sales figures over recent quarters, with total sales for FY 2025 expected to be negative at -₹0.22 Cr. Historical performance shows a dramatic decline from ₹5.15 Cr in FY 2014 to just ₹0.97 Cr in FY 2023. This trend raises concerns regarding the sustainability of operations and market demand for its products. The decline in revenue can be attributed to various factors, including market competition and operational inefficiencies. Additionally, the company reported a trailing twelve-month (TTM) sales figure of ₹0.00 Cr, indicating a complete halt in revenue generation.
Profitability and Efficiency Metrics
Profitability metrics for Envair Electrodyne Ltd signal significant challenges. The company posted a net profit of -₹0.64 Cr, reflecting ongoing losses. The operating profit margin (OPM) for the quarter ending September 2023 stood at -35.48%, indicating that the company is operating at a loss relative to its sales. In FY 2023, the operating profit was recorded at -₹1.00 Cr, down from -₹0.81 Cr in FY 2022. The return on equity (ROE) is currently at 5.88%, while the return on capital employed (ROCE) is notably low at 2.25%. The company’s interest coverage ratio (ICR) of 0.00x indicates that it does not generate sufficient earnings to cover its interest expenses. Furthermore, the cash conversion cycle (CCC) is reported at 0.00 days, suggesting potential operational inefficiencies. These metrics highlight the need for strategic changes to improve profitability and operational efficiency.
Balance Sheet Strength and Financial Ratios
Envair Electrodyne Ltd’s balance sheet reflects a cautious financial stance, with total borrowings recorded at ₹0.00 Cr, indicating no reliance on debt financing. The company holds reserves of ₹3.84 Cr, providing a buffer against operational losses. The current ratio is high at 14.73x, suggesting strong liquidity, while the quick ratio also stands at 14.73x, indicating an ability to cover short-term liabilities. However, the price-to-book value (P/BV) ratio at 5.32x is elevated compared to typical sector norms, which generally range lower, reflecting a potentially overvalued stock. The return on assets (ROA) stands at -5.23%, further emphasizing the inefficiency in asset utilization. The enterprise value (EV) is reported at ₹38.04 Cr, which, when compared with revenue, suggests that the market is not valuing the company’s revenue-generating capabilities favorably.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Envair Electrodyne Ltd indicates a majority stake held by promoters at 57.52%, while public shareholders own 42.49%. The number of shareholders has shown a gradual increase, rising from 2,604 in December 2022 to 2,734 by September 2025. This steady growth in shareholder numbers could reflect a degree of investor confidence despite the company’s financial challenges. However, the lack of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may signal a cautious stance from institutional players, who typically look for more stable financial performance. The promoter holding has remained consistent, which may provide some reassurance to retail investors regarding management’s commitment. Nonetheless, the overall investor sentiment may be tempered by the company’s ongoing losses and operational inefficiencies.
Outlook, Risks, and Final Insight
Looking ahead, Envair Electrodyne Ltd faces several risks, including its inability to generate sustainable revenue and ongoing operational losses. The lack of diversification in its product offerings may hinder growth opportunities in a competitive market. Additionally, the company’s high P/BV ratio could indicate overvaluation, which may result in downward pressure on stock prices if performance does not improve. However, strengths such as a zero-debt position and solid liquidity ratios could provide a foundation for recovery. Strategic initiatives aimed at improving operational efficiency and exploring new market opportunities could enhance revenue generation. For investors, closely monitoring the company’s quarterly performance and any potential changes in management strategy will be crucial in assessing its long-term viability. The company’s path forward will depend heavily on its ability to reverse current trends in profitability and operational efficiency.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Envair Electrodyne Ltd | 28.8 Cr. | 62.0 | 130/60.1 | 18.3 | 0.00 % | 2.25 % | 5.88 % | 10.0 | |
| Solex Energy Ltd | 1,083 Cr. | 1,002 | 1,985/631 | 20.7 | 167 | 0.05 % | 28.2 % | 38.7 % | 10.0 |
| Honda India Power Products Ltd | 2,216 Cr. | 2,186 | 3,256/1,815 | 29.2 | 750 | 4.58 % | 12.8 % | 9.47 % | 10.0 |
| Industry Average | 1,649.50 Cr | 1,083.33 | 24.95 | 311.77 | 1.54% | 14.42% | 18.02% | 10.00 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.89 | 0.00 | 0.00 | 0.31 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Expenses | 0.21 | 0.54 | 0.18 | 0.17 | 0.42 | 0.58 | 0.58 | 0.06 | 0.09 | 0.08 | 0.35 | 0.08 | 0.06 |
| Operating Profit | -0.21 | 0.35 | -0.18 | -0.17 | -0.11 | -0.58 | -0.58 | -0.06 | -0.09 | -0.08 | -0.35 | -0.08 | -0.06 |
| OPM % | 39.33% | -35.48% | |||||||||||
| Other Income | 0.00 | 0.03 | -2.22 | 0.21 | 0.01 | 0.00 | 0.16 | 0.20 | 0.33 | 0.11 | 0.12 | 0.21 | 0.13 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | -0.21 | 0.38 | -2.40 | 0.04 | -0.10 | -0.62 | -0.42 | 0.14 | 0.24 | 0.03 | -0.23 | 0.13 | 0.07 |
| Tax % | 0.00% | 0.00% | -22.08% | 125.00% | -10.00% | -82.26% | 45.24% | 0.00% | 0.00% | 2,133.33% | 0.00% | 0.00% | 0.00% |
| Net Profit | -0.21 | 0.38 | -1.87 | -0.01 | -0.09 | -0.11 | -0.60 | 0.14 | 0.24 | -0.61 | -0.23 | 0.13 | 0.07 |
| EPS in Rs | -0.45 | 0.82 | -4.03 | -0.02 | -0.19 | -0.24 | -1.29 | 0.30 | 0.52 | -1.31 | -0.50 | 0.28 | 0.15 |
Last Updated: December 27, 2025, 2:06 am
Below is a detailed analysis of the quarterly data for Envair Electrodyne Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Expenses, as of Sep 2025, the value is 0.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.08 Cr. (Jun 2025) to 0.06 Cr., marking a decrease of 0.02 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.06 Cr.. The value appears strong and on an upward trend. It has increased from -0.08 Cr. (Jun 2025) to -0.06 Cr., marking an increase of 0.02 Cr..
- For OPM %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Other Income, as of Sep 2025, the value is 0.13 Cr.. The value appears to be declining and may need further review. It has decreased from 0.21 Cr. (Jun 2025) to 0.13 Cr., marking a decrease of 0.08 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Depreciation, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.07 Cr.. The value appears to be declining and may need further review. It has decreased from 0.13 Cr. (Jun 2025) to 0.07 Cr., marking a decrease of 0.06 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.07 Cr.. The value appears to be declining and may need further review. It has decreased from 0.13 Cr. (Jun 2025) to 0.07 Cr., marking a decrease of 0.06 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.15. The value appears to be declining and may need further review. It has decreased from 0.28 (Jun 2025) to 0.15, marking a decrease of 0.13.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:46 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.15 | 5.53 | 4.12 | 4.76 | 4.07 | 3.38 | 3.49 | 0.79 | 4.49 | 0.97 | 0.40 | -0.22 | 0.00 |
| Expenses | 5.51 | 5.75 | 4.72 | 4.91 | 4.78 | 6.18 | 4.89 | 2.28 | 5.30 | 1.97 | 1.70 | 0.37 | 0.57 |
| Operating Profit | -0.36 | -0.22 | -0.60 | -0.15 | -0.71 | -2.80 | -1.40 | -1.49 | -0.81 | -1.00 | -1.30 | -0.59 | -0.57 |
| OPM % | -6.99% | -3.98% | -14.56% | -3.15% | -17.44% | -82.84% | -40.11% | -188.61% | -18.04% | -103.09% | -325.00% | ||
| Other Income | 0.71 | -0.48 | 0.17 | 0.06 | 4.41 | 0.15 | 0.07 | 0.08 | 0.22 | 8.81 | 0.29 | 0.77 | 0.57 |
| Interest | 0.02 | 0.04 | 0.05 | 0.11 | 0.12 | 0.05 | 0.06 | 0.09 | 0.09 | 0.02 | 0.09 | 0.00 | 0.00 |
| Depreciation | 0.28 | 0.21 | 0.15 | 0.11 | 0.11 | 0.08 | 0.10 | 0.10 | 0.09 | 0.01 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.05 | -0.95 | -0.63 | -0.31 | 3.47 | -2.78 | -1.49 | -1.60 | -0.77 | 7.78 | -1.10 | 0.18 | 0.00 |
| Tax % | -140.00% | -1.05% | 0.00% | 0.00% | 6.05% | 16.91% | 0.00% | 0.00% | 0.00% | 21.85% | -25.45% | 355.56% | |
| Net Profit | 0.11 | -0.94 | -0.63 | -0.31 | 3.25 | -3.25 | -1.50 | -1.61 | -0.77 | 6.08 | -0.81 | -0.47 | -0.64 |
| EPS in Rs | 0.36 | -3.09 | -2.07 | -1.02 | 10.69 | -10.69 | -3.23 | -3.47 | -1.66 | 13.10 | -1.75 | -1.01 | -1.38 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -954.55% | 32.98% | 50.79% | 1148.39% | -200.00% | 53.85% | -7.33% | 52.17% | 889.61% | -113.32% | 41.98% |
| Change in YoY Net Profit Growth (%) | 0.00% | 987.52% | 17.81% | 1097.59% | -1348.39% | 253.85% | -61.18% | 59.51% | 837.44% | -1002.93% | 155.30% |
Envair Electrodyne Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -100% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -7% |
| 5 Years: | 11% |
| 3 Years: | 12% |
| TTM: | 29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 37% |
| 1 Year: | -54% |
| Return on Equity | |
|---|---|
| 10 Years: | -25% |
| 5 Years: | -15% |
| 3 Years: | -9% |
| Last Year: | -6% |
Last Updated: September 5, 2025, 3:26 pm
Balance Sheet
Last Updated: December 4, 2025, 2:50 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 | 3.04 | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 | 4.64 |
| Reserves | 0.67 | -0.46 | -1.09 | -1.51 | 1.74 | -0.28 | 0.18 | -1.39 | -2.17 | 3.88 | 3.07 | 3.64 | 3.84 |
| Borrowings | 0.39 | 0.13 | 0.41 | 1.12 | 0.67 | 0.61 | 2.24 | 2.49 | 2.77 | 0.00 | 0.00 | 0.02 | 0.00 |
| Other Liabilities | 1.76 | 1.57 | 1.53 | 1.66 | 1.99 | 1.60 | 1.56 | 1.32 | 1.74 | 1.34 | 0.37 | 0.58 | 0.52 |
| Total Liabilities | 5.86 | 4.28 | 3.89 | 4.31 | 7.44 | 4.97 | 8.62 | 7.06 | 6.98 | 9.86 | 8.08 | 8.88 | 9.00 |
| Fixed Assets | 1.36 | 0.92 | 0.84 | 0.78 | 0.80 | 1.08 | 1.05 | 0.95 | 0.86 | 0.00 | 0.00 | 0.00 | 0.00 |
| CWIP | 0.00 | 0.07 | 0.07 | 0.13 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.26 | 2.46 | 2.46 |
| Other Assets | 4.50 | 3.29 | 2.98 | 3.40 | 6.56 | 3.81 | 7.49 | 6.03 | 6.04 | 9.86 | 6.82 | 6.42 | 6.54 |
| Total Assets | 5.86 | 4.28 | 3.89 | 4.31 | 7.44 | 4.97 | 8.62 | 7.06 | 6.98 | 9.86 | 8.08 | 8.88 | 9.00 |
Below is a detailed analysis of the balance sheet data for Envair Electrodyne Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 4.64 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.64 Cr..
- For Reserves, as of Sep 2025, the value is 3.84 Cr.. The value appears strong and on an upward trend. It has increased from 3.64 Cr. (Mar 2025) to 3.84 Cr., marking an increase of 0.20 Cr..
- For Borrowings, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 0.02 Cr. (Mar 2025) to 0.00 Cr., marking a decrease of 0.02 Cr..
- For Other Liabilities, as of Sep 2025, the value is 0.52 Cr.. The value appears to be improving (decreasing). It has decreased from 0.58 Cr. (Mar 2025) to 0.52 Cr., marking a decrease of 0.06 Cr..
- For Total Liabilities, as of Sep 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.88 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 0.12 Cr..
- For Fixed Assets, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 2.46 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 2.46 Cr..
- For Other Assets, as of Sep 2025, the value is 6.54 Cr.. The value appears strong and on an upward trend. It has increased from 6.42 Cr. (Mar 2025) to 6.54 Cr., marking an increase of 0.12 Cr..
- For Total Assets, as of Sep 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.88 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 0.12 Cr..
Notably, the Reserves (3.84 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -0.75 | -0.35 | -1.01 | -1.27 | -1.38 | -3.41 | -3.64 | -3.98 | -3.58 | -1.00 | -1.30 | -0.61 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 122.61 | 98.35 | 102.77 | 108.89 | 176.67 | 96.11 | 106.68 | 314.18 | 50.40 | 395.10 | 0.00 | 0.00 |
| Inventory Days | 48.41 | 72.29 | 60.06 | 88.16 | 118.67 | 133.40 | 129.13 | 404.82 | 39.14 | 117.54 | 0.00 | 0.00 |
| Days Payable | 126.90 | 104.29 | 100.11 | 102.08 | 116.87 | 116.73 | 113.63 | 358.36 | 57.00 | 123.73 | ||
| Cash Conversion Cycle | 44.12 | 66.35 | 62.72 | 94.97 | 178.47 | 112.78 | 122.17 | 360.63 | 32.53 | 388.92 | 0.00 | 0.00 |
| Working Capital Days | 170.81 | 112.21 | 59.36 | 32.97 | 326.44 | 33.48 | 55.43 | 582.15 | 190.22 | 451.55 | 100.38 | -132.73 |
| ROCE % | -15.05% | -8.22% | -22.88% | -8.38% | -15.80% | -62.36% | -27.42% | -23.59% | -12.39% | -8.43% | -12.45% | 2.25% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -1.00 | -1.76 | 13.11 | -1.67 | -3.39 |
| Diluted EPS (Rs.) | -1.00 | -1.76 | 13.11 | -1.67 | -3.39 |
| Cash EPS (Rs.) | -1.00 | -1.75 | 13.12 | -1.46 | -3.24 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 17.84 | 16.61 | 18.37 | 5.33 | 6.99 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 17.84 | 16.61 | 18.37 | 5.33 | 6.99 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.85 | 2.09 | 9.99 | 1.70 |
| PBDIT / Share (Rs.) | 0.38 | -2.26 | -1.26 | -1.36 | -3.14 |
| PBIT / Share (Rs.) | 0.38 | -2.26 | -1.27 | -1.56 | -3.36 |
| PBT / Share (Rs.) | 0.38 | -2.36 | 16.78 | -1.66 | -3.46 |
| Net Profit / Share (Rs.) | -1.00 | -1.75 | 13.11 | -1.66 | -3.46 |
| PBDIT Margin (%) | 0.00 | -264.57 | -59.96 | -13.60 | -184.37 |
| PBIT Margin (%) | 0.00 | -264.57 | -60.55 | -15.59 | -197.28 |
| PBT Margin (%) | 0.00 | -275.78 | 801.06 | -16.61 | -203.10 |
| Net Profit Margin (%) | 0.00 | -205.08 | 625.68 | -16.61 | -203.10 |
| Return on Networth / Equity (%) | -5.62 | -10.56 | 71.35 | -31.17 | -49.49 |
| Return on Capital Employeed (%) | 2.10 | -13.63 | -6.90 | -15.29 | -29.58 |
| Return On Assets (%) | -5.23 | -10.08 | 62.11 | -11.03 | -22.74 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 0.91 | 0.62 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.00 | 1.12 | 0.76 |
| Asset Turnover Ratio (%) | 0.00 | 0.04 | 0.11 | 0.66 | 0.10 |
| Current Ratio (X) | 14.73 | 17.60 | 7.58 | 2.60 | 3.27 |
| Quick Ratio (X) | 14.73 | 17.60 | 7.27 | 2.40 | 2.93 |
| Inventory Turnover Ratio (X) | 0.00 | 2.08 | 0.49 | 8.05 | 0.69 |
| Interest Coverage Ratio (X) | 0.00 | -23.62 | 0.00 | -13.34 | -31.66 |
| Interest Coverage Ratio (Post Tax) (X) | 0.00 | -17.31 | 0.00 | -15.28 | -33.88 |
| Enterprise Value (Cr.) | 38.04 | 91.76 | 22.09 | 11.63 | 14.19 |
| EV / Net Operating Revenue (X) | 0.00 | 231.01 | 22.73 | 2.51 | 17.94 |
| EV / EBITDA (X) | 214.18 | -87.31 | -37.90 | -18.43 | -9.73 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 246.02 | 29.57 | 2.20 | 18.33 |
| Price / BV (X) | 5.32 | 12.68 | 3.37 | 4.13 | 4.47 |
| Price / Net Operating Revenue (X) | 0.00 | 246.03 | 29.58 | 2.20 | 18.34 |
| EarningsYield | -0.01 | -0.01 | 0.21 | -0.07 | -0.11 |
After reviewing the key financial ratios for Envair Electrodyne Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 5. It has increased from -1.76 (Mar 24) to -1.00, marking an increase of 0.76.
- For Diluted EPS (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 5. It has increased from -1.76 (Mar 24) to -1.00, marking an increase of 0.76.
- For Cash EPS (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 3. It has increased from -1.75 (Mar 24) to -1.00, marking an increase of 0.75.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.84. It has increased from 16.61 (Mar 24) to 17.84, marking an increase of 1.23.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.84. It has increased from 16.61 (Mar 24) to 17.84, marking an increase of 1.23.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 0.85 (Mar 24) to 0.00, marking a decrease of 0.85.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has increased from -2.26 (Mar 24) to 0.38, marking an increase of 2.64.
- For PBIT / Share (Rs.), as of Mar 25, the value is 0.38. This value is within the healthy range. It has increased from -2.26 (Mar 24) to 0.38, marking an increase of 2.64.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.38. This value is within the healthy range. It has increased from -2.36 (Mar 24) to 0.38, marking an increase of 2.74.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -1.00. This value is below the healthy minimum of 2. It has increased from -1.75 (Mar 24) to -1.00, marking an increase of 0.75.
- For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -264.57 (Mar 24) to 0.00, marking an increase of 264.57.
- For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -264.57 (Mar 24) to 0.00, marking an increase of 264.57.
- For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -275.78 (Mar 24) to 0.00, marking an increase of 275.78.
- For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -205.08 (Mar 24) to 0.00, marking an increase of 205.08.
- For Return on Networth / Equity (%), as of Mar 25, the value is -5.62. This value is below the healthy minimum of 15. It has increased from -10.56 (Mar 24) to -5.62, marking an increase of 4.94.
- For Return on Capital Employeed (%), as of Mar 25, the value is 2.10. This value is below the healthy minimum of 10. It has increased from -13.63 (Mar 24) to 2.10, marking an increase of 15.73.
- For Return On Assets (%), as of Mar 25, the value is -5.23. This value is below the healthy minimum of 5. It has increased from -10.08 (Mar 24) to -5.23, marking an increase of 4.85.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 0.00.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.04 (Mar 24) to 0.00, marking a decrease of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 14.73. This value exceeds the healthy maximum of 3. It has decreased from 17.60 (Mar 24) to 14.73, marking a decrease of 2.87.
- For Quick Ratio (X), as of Mar 25, the value is 14.73. This value exceeds the healthy maximum of 2. It has decreased from 17.60 (Mar 24) to 14.73, marking a decrease of 2.87.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 2.08 (Mar 24) to 0.00, marking a decrease of 2.08.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -23.62 (Mar 24) to 0.00, marking an increase of 23.62.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 3. It has increased from -17.31 (Mar 24) to 0.00, marking an increase of 17.31.
- For Enterprise Value (Cr.), as of Mar 25, the value is 38.04. It has decreased from 91.76 (Mar 24) to 38.04, marking a decrease of 53.72.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 231.01 (Mar 24) to 0.00, marking a decrease of 231.01.
- For EV / EBITDA (X), as of Mar 25, the value is 214.18. This value exceeds the healthy maximum of 15. It has increased from -87.31 (Mar 24) to 214.18, marking an increase of 301.49.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 246.02 (Mar 24) to 0.00, marking a decrease of 246.02.
- For Price / BV (X), as of Mar 25, the value is 5.32. This value exceeds the healthy maximum of 3. It has decreased from 12.68 (Mar 24) to 5.32, marking a decrease of 7.36.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 246.03 (Mar 24) to 0.00, marking a decrease of 246.03.
- For EarningsYield, as of Mar 25, the value is -0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded -0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Envair Electrodyne Ltd:
- Net Profit Margin: 0%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 2.1% (Industry Average ROCE: 14.42%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -5.62% (Industry Average ROE: 18.02%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 0
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 14.73
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 24.95)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Electric Equipment - Gensets/Turbines | Office No 123, Wing A Sohrab Hall, 21 Pune Maharashtra 411001 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Anil Nagpal | Managing Director |
| Mr. Harish Kumar Agarwal | Director |
| Mr. Satish Kumar Avasthi | Independent Director |
| Ms. Rashmi Sharma | Independent Director |
FAQ
What is the intrinsic value of Envair Electrodyne Ltd?
Envair Electrodyne Ltd's intrinsic value (as of 07 February 2026) is ₹13.84 which is 77.68% lower the current market price of ₹62.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹28.8 Cr. market cap, FY2025-2026 high/low of ₹130/60.1, reserves of ₹3.84 Cr, and liabilities of ₹9.00 Cr.
What is the Market Cap of Envair Electrodyne Ltd?
The Market Cap of Envair Electrodyne Ltd is 28.8 Cr..
What is the current Stock Price of Envair Electrodyne Ltd as on 07 February 2026?
The current stock price of Envair Electrodyne Ltd as on 07 February 2026 is ₹62.0.
What is the High / Low of Envair Electrodyne Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Envair Electrodyne Ltd stocks is ₹130/60.1.
What is the Stock P/E of Envair Electrodyne Ltd?
The Stock P/E of Envair Electrodyne Ltd is .
What is the Book Value of Envair Electrodyne Ltd?
The Book Value of Envair Electrodyne Ltd is 18.3.
What is the Dividend Yield of Envair Electrodyne Ltd?
The Dividend Yield of Envair Electrodyne Ltd is 0.00 %.
What is the ROCE of Envair Electrodyne Ltd?
The ROCE of Envair Electrodyne Ltd is 2.25 %.
What is the ROE of Envair Electrodyne Ltd?
The ROE of Envair Electrodyne Ltd is 5.88 %.
What is the Face Value of Envair Electrodyne Ltd?
The Face Value of Envair Electrodyne Ltd is 10.0.